Frederic Pla was named chief operating officer of The Parker Institute for Cancer Immunotherapy.
The intersection of art and education is well established, but its application in oncology remains limited.
Frederic Pla named COO of The Parker Institute for Cancer Immunotherapy
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
In recent months, several directors of cancer centers, appearing on The Directors, a segment of The Cancer Letter Podcast, mentioned that their institutions are increasingly providing small grants—typically in the range of $50,000—to scientists to enable them to keep their labs open.
Tucked in at the end of a 20-minute talk that covered paylines, promising young investigators, and precision medicine, NCI Director Anthony G. Letai beefed up the alliteration with two more words that begin with a “p”: prevention and pilot.
In theory, cervical cancer could be almost entirely eliminated with prevention and screening efforts, thanks to a quirk of the disease’s histology: Virtually all cases are caused by high-risk human papillomavirus, for which there is both a vaccine and an effective screening test.Â
Cancer survivorship in the United States now tops 18 million people. That is a lot of people walking around with a shared experience, and yet somehow we barely talk about what surviving cancer actually does to you.
On April 28, 1986, when a radioactive plume reached Sweden, the world discovered that there had been a huge accident at the Chernobyl nuclear power facility in Ukraine. The accident had occurred two days earlier, and the details were hidden by Soviet authorities.
